Longitude Capital is a venture capital firm in California that focuses on biotechnology and medical technology companies. Founded 2006 in Menlo Park, California, United States by David Hirsch, Marc Galletti, and Patrick Enright, it invests in debt, early stage ventures, late stage ventures, private equity, series A, post-IPO equity, and series B rounds. Its portfolio companies include SutroVax, Amunix, Epirium Bio, Poseida Therapeutics, Talaris Therapeutics, Inozyme, Encore Dermatology, Tiburio Therapeutics, 89bio and CuraSen Therapeutics. As of April 2020, Longitude Capital has made 71 investments. Their most recent investment was on March 6, 2020, when SutroVax raised $110M. Longitude Capital has had 21 exits, the most notable of which include Aimmune Therapeutics, Practice Fusion, and Axonics Modulation Technologies. the company has raised six funds, their latest being Longitude Venture Partners IV, L.p. This fund was announced on September 23, 2019 and raised a total of $550M.
A biopharmaceutical company that develops pulmonary delivery therapies.
An independent vaccine platform in California that focuses on delivering best-in-class conjugate vaccines and complex antigen-based vaccines to prevent deadly infectious diseases.
A cardiovascular genomic diagnostics company that provides clinicians information to improve patient care
A biotechnology company the develops tools for detection of microbial contamination
Solta Medical is a Pleasanton, California-based healthcare company.
KaNDy Therapeutics is a clinical-stage company focused on optimising the potential of NT-814 in the treatment of common, chronic debilitating female sex-hormone related conditions, with an initial focus on symptoms of the menopause.
A medical device company developing therapeutic hypothermia for patients suffering from cardiac arrest and heart attack
Dascena is an Oakland, California-based machine learning company developing algorithms for early diseases intervention and care outcomes.
Esperion Therapeutics is an Ann Arbor, Michigan-based company.
A company developing immunotoxins for the treatment of cancer
A company developing drugs for orphan and rare diseases
Alphaeon is an Irvine, California-based healthcare company founded in 2013.
Checkmate Pharmaceuticals is a Cambridge, Massachusetts-based company.
Aimmune Therapeutics is a Brisbane, California-based company.
Associated investment funds
Juliet Tammenoms Bakker
Co-Founder and Managing Director
Reinaldo M. Diaz
Documentaries, videos and podcasts